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Abstract
Men who have sex with men (MSM) are disproportionally affected by the HIV epidemic. Self-efficacy is an important
individual psychosocial factor associated with access to and use of health and HIV-related services. We estimated HIV
testing prevalence and examined the relationship between HIV testing self-efficacy and self-reported HIV testing behav-
ior among young MSM (YMSM) in Myanmar. We enrolled 585 MSM aged 18–24 years from six urban areas using
respondent-driven sampling (RDS) technique. RDS analyses were performed to provide estimates for the key outcome
of interest. More than a third (34.5%) had never been tested for HIV, whereas 27.5% and 38.0% had their most recent
HIV test more than three months and within the past three months from the time of interview, respectively. Young MSM
who reported high self-efficacy (adjusted relative risk ratio [ARR]¼7.35, 95%CI¼ 2.29–23.5) and moderate self-efficacy
(ARR¼ 8.61, 95%CI¼ 3.09–24.0) were more likely to report having tested for HIV in the past three months compared
to their counterparts who reported low self-efficacy. Findings highlight a positive association between self-efficacy and
HIV testing uptake, indicating a potential causal relationship. Further research is needed to examine the direction of this
association and inform future public health interventions targeting YMSM in Myanmar.
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Introduction
Compared to the general population, men who have
sex with men (MSM) are at greater risk of HIV infec-
tion in nearly all studied contexts.1–4 Compared to their
age peers in the general population, young MSM
(YMSM) are more likely to engage in high-risk behav-
iors such as having condomless anal intercourse and
are more vulnerable to HIV infection.5,6 Published
data showed a global ongoing high HIV incidence—
particularly among adolescents and YMSM, with an
overall trend suggesting a greater burden of HIV infec-
tion in low- and middle-income countries (LMICs).7–11
It is recommended that MSM, including YMSM, who
engage in high-risk behaviors should have an HIV test
every three months.12
Self-efficacy is defined as individual’s belief in his or
her capacity to execute behavior necessary to produce
1Burnet Institute, Melbourne, Victoria, Australia
2Department of Epidemiology and Preventive Medicine, Faculty of
Medicine Nursing and Health Science, Monash University,
Melbourne, Australia
3Burnet Institute, Yangon, Myanmar
4Judith Lumley Centre, La Trobe University, Melbourne,Victoria, Australia
5Population Council, Washington DC, USA
6Population Council, Phnom Penh, Cambodia
7International Centre for Reproductive Health, Department of
Obstetrics and Gynecology, Faculty of Medicine and Health Sciences,
Ghent University, Belgium
Corresponding author:
Minh D Pham, Burnet Institute, 85 Commercial Road, Melbourne,
Victoria 3004, Australia.
Email: minh.pham@burnet.edu.au
International Journal of STD & AIDS
2019, Vol. 30(1) 20–28
! The Author(s) 2018
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0956462418791945
journals.sagepub.com/home/std
specific performance attainment.13 Perceived self-
efficacy for specific health behavior is a social cognitive
factor that has been highlighted in the Health Action
Process Approach. This model of health behavior
change stipulates that the adoption and maintenance
of health behaviors require two distinct processes:
motivation to change and self-regulation. Within
these processes, different social cognitive predictors
may emerge and self-efficacy appears as the only pre-
dictor that is equally important in both processes.14
Previous research has shown that health-related self-
efficacy contributes to the likelihood of having access
to health care and is associated with health outcomes:
higher self-efficacy is associated with having multiple
points of connection to the health care system,15 while
lower self-efficacy is associated with higher burden of
chronic diseases.16
Recent studies have examined the importance of
psychosocial factors in HIV testing uptake;17 however,
data on the relationship of self-efficacy and HIV testing
behavior, particularly from low-resource settings, are
limited and not consistent. This is partly because dif-
ferent measures of self-efficacy had been used among
different study populations in different settings.18–20
For example, a study among HIV-negative incarcerat-
ed adult men reported that men with high HIV coping
self-efficacy are more likely to be tested for HIV,21
while another study among females using shelter serv-
ices for intimate partner violence found that general
self-efficacy for handling difficult situations, measured
by 10 items general self-efficacy scale (GSE), has no
effects on the acceptance of HIV testing.22
Our previous study showed that self-efficacy was
correlated with HIV testing uptake among YMSM in
Myanmar, a LMIC with a concentrated HIV epidemic
among key populations.23 In this present analysis, we
aim to estimate HIV testing prevalence and examine
the relationship between different levels of HIV testing
self-efficacy and self-reported HIV testing behavior of
YMSM aged 18–24 years from six urban areas
of Myanmar.
Methods
Study design
This is a cross-sectional study using data from the eval-
uation of the Link-Up project, a global HIV and sexual
reproductive health project led by the International
HIV/AIDS Alliance, with YMSM in Myanmar. The
project implemented a combined community-based
peer education and clinic-based service intervention
to improve the health of YMSM. The interventions
were implemented for six months from October 2014
and data for the evaluation study were collected
between April and June 2015. Details of project inter-
ventions and the evaluation study design, including
study population, data collection, and study measures
have been reported elsewhere.24 Briefly, potential par-
ticipants who self-identified as YMSM aged 18–24
years, living in six urban areas (Pathein,
Mawlamyine, Bago, Kalay, Magwe, and Thanlyin) of
Myanmar and reported having sexual intercourse with
other men in the past six months were recruited into the
study using respondent-driven-sampling (RDS).14
A total of 585 MSM were recruited by 33 seed respond-
ents to participate in face-to-face interviews with a
trained MSM data collector using study tools adapted
from a validated questionnaire for a sexual health
study among MSM in Kenya.25 The questionnaire
was translated to local language by a researcher who
is fluent in both English and Burmese. The final ques-
tionnaire was reviewed by the research team to ensure
clarity and consistency between English and
Burmese versions.
In order to examine factors associated with uptake
and the temporal nature of HIV testing among
YMSM, we constructed an outcome variable for the
main outcome of interest “HIV testing status” with
three groups including never tester (never been tested
for HIV), nonrecent tester (having most recent HIV test
more than three months ago), and recent tester (having
an HIV test in the past three months). Other study
measures include: (i) main exposure “Self-efficacy for
HIV testing” measured using a single-item response on
a five-point Likert scale to the statement “I feel confi-
dent that I could get tested for HIV” (1¼ strongly dis-
agree; 5¼ strongly agree), respondents with responses
1–3, 4, and 5 were coded as having low, moderate, and
high self-efficacy, respectively; and (ii) potential con-
founders including socio-demographics (sexual identi-
ties: gay- and nongay-identified MSM, age, ethnicity,
education, occupation, relationship status), sexual
behavior (multiple sexual partners, engaged in transac-
tional sex, reported sexually transmitted infection [STI]
symptoms), and other psychosocial variables related to
HIV testing (HIV-related knowledge, experienced
social stigma due to sexual orientation, disclosure of
sexual orientation, knowing sexual partners’ HIV
status, having a close relative/friend infected
with HIV).
Statistical analysis
Descriptive statistics were used to summarize the char-
acteristics of study participants by outcome of interest
(HIV testing status). Respondent-driven sampling
(RDS) analyses for outcome of interest using RDS-II
(Volz-Heckathorn) estimators26 with final reported
sample including seeds27 were performed to provide
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population estimates28 for coverage of HIV testing
among YMSM in Myanmar. There were 12 partici-
pants including one seed who reported being HIV pos-
itive. To keep the sampling structure and recruitment
matrix of the RDS sample intact, given a small number
of HIV-positive participants, all self-reported HIV-pos-
itive participants were included in the analyses. A sen-
sitivity analysis was performed to assess the potential
impact of inclusion of seeds and self-reported HIV-pos-
itive participants on the final RDS estimates.
Nested multinomial logistic regression models were
built to examine the relationship between self-efficacy
and HIV testing status, with YMSM who had never
tested for HIV treated as the outcome reference
group. Cluster robust standard errors29 were specified
to account for clustering of the sample around the
seeds. Independent effects for three specific groups of
potential confounding variables—socio-demographic,
psychosocial, and sexual behavior factors—were also
estimated in multinomial regression modeling. We
used univariable-filtering approach for variable selec-
tion. Only variables that were significantly associated
with the outcome of interest at p< 0.1 in bivariate
analyses were included in multivariate analyses. Post-
estimation joint Wald tests were used to assess the sta-
tistically significant contribution of covariates
across outcomes.
Interactions between self-efficacy and other covari-
ates that might influence HIV testing status were
assessed. More specifically, interactions between self-
efficacy and sexual identity were assessed to examine
whether the effects of self-efficacy on HIV testing status
were moderated by sexual identity. A complete case
approach to missing data was applied. All statistical
analyses were undertaken using Stata version 13.1
(STATA Corp, College Station, TX, USA) and Stata
user written command package SPost13.30
Ethics
The study was approved by the Department of Medical
Research in Myanmar, the Population Council
Institutional Review Board in USA, and the Alfred
Hospital Human Research Ethics Committee
in Australia.
Results
A total of 585 MSM were enrolled in the study. Table 1
presents the characteristics of the study participants.
The mean age was 20.8 years (SD¼ 1.9). Ninety-one
percent of participants self-identified as Burmese ethi-
nicity and had completed middle school or higher, 58%
identified themselves as nongay MSM, and 42% as gay
MSM. Eighty-four percent of participants who had
never been tested for HIV (never testers) were nongay
MSM, while only 43% of participants who had an HIV
test in the past three months (recent testers) belonged
to this sexual identity group. Among the recent testers,
58% reported moderate and 39% reported high self-
efficacy. For the nonrecent and never testers, the per-
centages of YMSM who reported moderate and high
self-efficacy were 54%, 41%, 45%, and 37%,
respectively.
RDS-population estimates including seed data
showed that 38.0% (95%CI: 33.1–43.0) of YMSM in
Myanmar have had an HIV test in the past three
months, 27.5% (95%CI: 22.9–32.0) had their HIV
test more than three months before the time of inter-
view, and 34.5% (95%CI: 29.7–39.5) had never been
tested (Table 2). Sensitivity RDS analysis without seed
data provided similar point estimates with wider 95%
CIs. Similar results were found with 12 HIV-positive
participants dropped from the analysis.
Bivariate analyses suggested that self-efficacy and all
other variables except “education” and “reported STI
symptoms in the past 12 months” were significantly
associated with HIV testing status (Table 1). Results
of multivariate multinomial regression analyses
(Table 3) showed an association between self-efficacy
on HIV testing status among YMSM. The introduction
of potential confounders into the regression models did
not attenuate the associations. In the final model, Joint
Wald tests showed that self-efficacy (p¼ 0.001), socio-
demographic (p< 0.001), and psychosocial factors
(p< 0.001) were independently associated with HIV
testing but sexual behavior factors were not associated
with HIV testing conditional on the other fac-
tors (p¼ 0.067).
YMSM who reported moderate self-efficacy (adjust-
ed relative risk ratio [ARR]¼ 8.61, 95%CI: 3.09–24.0)
and high self-efficacy (ARR¼ 7.35, 95%CI: 2.29–23.5)
were more likely to have tested for HIV in the past
three months (recent testers) compared to their peers
who reported low self-efficacy. Similarly, YMSM who
reported moderate self-efficacy (ARR¼ 6.09, 95%CI:
2.08–17.80) and high self-efficacy (ARR¼ 6.50, 95%
CI: 2.08–20.4) were more likely to report being a non-
recent tester compared to their peers who reported low
self-efficacy.
In further analyses, we introduced an interaction
term to explore whether the association between HIV
testing and self-efficacy was moderated by sexual iden-
tity. Although we found the effect of self-efficacy on
HIV testing uptake was more pronounced for those
identifying as gay (nonrecent testing: moderate self-
efficacy ARRs¼ 8.3 vs. 6.3, high self-efficacy
ARRs¼ 8.6 vs. 6.1; recent testing: moderate self-
efficacy ARRs¼ 23.1 vs. 4.1, high self-efficacy
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Table 1. Characteristics of young MSM aged 18–24 years in six urban areas of Myanmara disaggregated by HIV testing status,
October 2014 to June 2015.
All (n/N, % col)
HIV testing statusb
(n/N, %col)
p-Values
(v2 test of
independence
except
otherwise noted)
Recent tester
(tested for HIV
in past three
months)
Nonrecent tester
(tested for HIV
prior to three
months ago) Never tester
Social-demographics
Age (years) mean, SD 20.8 (1.9) 20.6 (1.9) 21.4 (2.0) 20.4 (1.9) <0.001c
Sexual identity <0.001
Nongay identified 337/585 (57.6) 104/240 (43.3) 86/170 (50.6) 147/175 (84.0)
Gay identified 248/585 (42.4) 136/240 (56.7) 84/170 (49.4) 28/175 (16.0)
Ethnicity 0.004
Non-Burma 50/576 (8.7) 29/238 (12.2) 16/167 (9.6) 5/171 (2.9)
Burma 526/576 (91.3) 209/238 (87.8) 151/167 (90.4) 166/171 (97.1)
Education 0.842
Primary school 54/583 (9.2) 24/239 (10.0) 15/169 (8.9) 15/175 (8.6)
Middle/high school 412/583 (70.7) 170/239 (71.1) 122/169 (72.2) 120/175 (68.6)
College or University 117/583 (20.1) 45/239 (18.9) 32/169 (18.9) 40/175 (22.8)
Employment 0.027
Unemployed 135/584 (23.1) 48/239 (20.1) 34/170 (20.0) 53/175 (30.3)
Employed 449/584 (76.9) 191/239 (79.9) 136/170 (80.0) 122/175 (69.7)
Relationship 0.032
Never in a relationship 486/585 (83.1) 191/240 (79.6) 139/170 (81.8) 156/175 (89.1)
Current/previously in
a relationship
99/585 (16.9) 49/240 (20.4) 31/170 (18.2) 19/175 (10.9)
Psychosocial factors
Self-efficacy for HIV testing <0.001
Low 47/585 (8.0) 7/240 (2.9) 8/170 (4.7) 32/175 (18.3)
Moderate 310/585 (53.0) 140/240 (58.3) 92/170 (54.1) 78/175 (44.6)
High 228/585 (39.0) 93/240 (38.8) 70/170 (41.2) 65/175 (37.1)
Have good HIV-related knowledged 0.007
Yes 217/572 (37.9) 104/238 (43.7) 65/165 (39.4) 48/169 (28.4)
No 355/572 (62.1) 134/238 (56.3) 100/165 (60.6) 121/169 (71.6)
Have close relative/friend infected with HIV <0.001
Yes 311/585 (53.2) 143/240 (59.6) 108/170 (63.5) 60/175 (34.3)
No 274/585 (46.8) 97/240 (40.4) 62/170 (36.5) 115/175 (65.7)
Know sexual partner HIV status 0.003
Yes 138/585 (23.6) 70/240 (29.2) 42/170 (24.7) 26/175 (14.9)
No 447/585 (76.4) 170/240 (70.8) 128/170 (75.3) 149/175 (85.1)
Experienced social stigma due to sexual orientation in the past 12 months 0.016
Yes 139/585 (23.7) 65/240 (27.1) 46/170 (27.1) 28/175 (16.0)
No 446/585 (76.3) 175/240 (72.9) 124/170 (72.9) 147/175 (84.0)
Disclose sexual orientation to others 0.047
Yes 405/585 (69.2) 178/240 (74.2) 117/170 (68.8) 110/175 (62.9)
No 180/585 (30.8) 62/240 (25.8) 53/170 (31.2) 65/175 (37.1)
Sexual behaviors and STI
Had multiple (3) male sexual partners in the past 12 months 0.003
Yes 385/573 (67.2) 172/235 (73.2) 115/167 (68.9) 98/171 (57.3)
No 188/573 (32.8) 63/235 (26.8) 52/167 (31.1) 73/171 (42.7)
Engaged in transactional sex (selling sex to other) in the past 30 days 0.034
Yes 96/585 (16.4) 49/240 (20.4) 28/170 (16.5) 19/175 (10.9)
No 489/585 (83.6) 191/240 (79.6) 142/170 (83.5) 156/175 (89.1)
Reported STI symptoms in the past 12 months 0.188
Yes 106/585 (18.1) 51/240 (21.3) 30/170 (17.6) 25/175 (14.3)
No 479/585 (81.9) 189/249 (78.7) 140/170 (82.4) 150/175 (85.7)
aData from all study participants are included in descriptive analysis except otherwise as noted due to missing data.
bValues are expressed as mean (standard deviation) for age and or n/N (percent) for all other variables.
cOne-way ANOVA.
dHIV-related knowledge was measured by six common questions on HIV transmission/prevention (e.g. Can a person get HIV from a mosquito bite?),
participants who answer all questions correctly were categorized as having good HIV-related knowledge.
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Table 2. RDS population estimatesa of HIV testing prevalence among young MSM aged 18–24 years in six urban areas of Myanmar,
October 2014 to June 2015.
HIV testing statusb
Sample
estimates
(N%)
Population estimates
calculated using data
from all participants
Population estimates
calculated excluding
seed participants
Population estimates
calculated excluding HIV
positive participants
% 95%CI % 95%CI % 95%
Recent tester 240 (41.0) 38.0 33.1–43.0 36.6 31.5–42.0 38.6 33.9–43.7
Nonrecent tester 170 (29.1) 27.5 22.9–32.0 25.6 21.0–30.4 26.1 21.7–30.6
Never tester 175 (29.9) 34.5 29.7–39.5 37.8 32.5–43.0 35.3 30.3–40.4
aPopulation estimates calculated using RDS II (Volz–Heckathorn) estimators, 95% CIs obtained using bootstrapping method with 1000 replications.
bRecent tester: Tested for HIV in past 3 months; Nonrecent tester: Tested for HIV prior to 3 months ago; Never tester: Never tested for HIV.
Table 3. Multinomial logistic regression modeling exploring the association between HIV testing statusa and self-efficacy, adjusted for
socio-demographic, psychosocial, and sexual behavior factorsb among young MSM aged 18–24 years in six urban areas of Myanmar,
October 2014 to June 2015 (n¼ 548).
Variablesc
Adjusted relative risk ratio – ARR (95%CI),d p-values
Joint Wald v2
(degree of
freedom),
p-values
Recent tester
vs. Never tester
Nonrecent tester
vs. Never tester
Recent tester
vs. Nonrecent tester
ARR (95%CI) p-values ARR (95%CI) p-values ARR (95%CI) p-values
Self-efficacy v2(4)¼ 19.0,
p¼0.001Moderate self-efficacy 8.61 (3.09–24.0) <0.001 6.09 (2.08–17.8) 0.001 1.41 (0.54–3.69) 0.480
High self-efficacy 7.35 (2.29–23.5) 0.001 6.50 (2.08–20.4) 0.001 1.13 (0.45–2.81) 0.793
Socio-demographic factors v2(10)¼ 91.8,
p<0.001Sexual identity (gay-identified) 4.39 (2.59–7.45) <0.001 3.07 (1.96–4.81) <0.001 1.43 (0.91–2.26) 0.125
Ethnicity (non-Burma) 4.18 (1.36–12.9) 0.013 3.34 (0.91–12.2) 0.069 1.26 (0.61–2.58) 0.536
Employment
status (employed)
1.89 (1.01–3.58) 0.048 1.30 (0.63–2.69) 0.484 1.46 (0.81–2.63) 0.204
Currently or previously
in a relationship
1.53 (0.89–2.63) 0.121 1.11 (0.58–2.10) 0.761 1.39 (0.84–2.30) 0.205
Age 0.91 (0.81–1.02) 0.109 1.19 (1.06–1.33) 0.004 0.76 (0.68–0.86) <0.001
Psychosocial factors v2(8)¼ 49.0,
p<0.001Have good
HIV-related knowledge
1.81 (1.15–2.87) 0.011 1.59 (0.99–2.57) 0.056 1.14 (0.80–1.63) 0.472
Have close relative/friend
infected with HIV or died
of AIDS
2.20 (1.51–3.21) <0.001 2.75 (1.90–3.97) <0.001 0.80 (0.53–1.21) 0.294
Know partner HIV status 1.56 (0.87–2.79) 0.140 1.13 (0.72–1.79) 0.596 1.37 (0.86–2.19) 0.182
Experienced social stigma
due to sexual orientation
in the past 12 months
0.95 (0.49–1.84) 0.877 1.07 (0.46–2.47) 0.881 0.89 (0.57–1.39) 0.609
Sexual behavior factors v2(4)¼ 8.8,
p¼0.067Had multiple (3) male
sexual partners in the
past 12 months
1.83 (1.05–3.19) 0.034 1.45 (0.73–2.88) 0.289 1.26 (0.70–2.27) 0.442
Engaged in transactional sex
(selling sex to others) in
the past 30 days
1.33 (0.68–2.60) 0.402 1.27 (0.59–2.73) 0.536 1.05 (0.64–1.69) 0.856
aRecent tester: Tested for HIV in past three months; Nonrecent tester: Tested for HIV prior to three months ago; Never tester: Never tested for HIV.
bPotential confounders to be included in the multivariate multinomial regression model if found significantly associated with outcome at p< 0.1 in
bivariate analyses.
cReference group for self-efficacy is low-self-efficacy, that for sexual identity is nongay identified, that for ethnicity is Burma ethnic, and that for
employment status and currently or previously in a relationship is unemployed and never in a relationship, respectively. Psychosocials and sexual
behaviors variables are binary (Yes/No) and “No” are reference groups.
dRobust standard errors to account for clustering by seeding.
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ARRs¼ 14.4 vs. 4.3); jointly these moderated effects
were not statistically significant (p¼ 0.312).
Discussion
Findings from this study shows that HIV testing self-
efficacy positively correlates with HIV testing behavior
of YMSM aged 18–24 years in Myanmar. This finding
is in line with findings from other studies among MSM
conducted in high resource settings showing that self-
efficacy was positively associated with acceptance and
frequency of HIV testing among adult MSM.18,31–33 It
is noted that in these studies, HIV testing self-efficacy
was discussed; however, the measurements of self-
efficacy were varied across these studies with authors
using either a single-item statement to measure partic-
ipant’s confidence in obtaining an HIV test if
desired31,32 or an opportunistically constructed scale
with five or eight items to measure the extent to
which participant’s thought that having an HIV test
was under their control if they choose to.18,33
Traditionally, the use of single-item measures of
cognitive variables has been criticized due to concern
regarding their psychometric properties. However, cur-
rent research has shown that single-item measures
of latent constructs such as self-efficacy, compared to
well-established multi-item measures, has equal or even
superior predictive utility in predicting health-related
outcomes. A single-item measure of self-efficacy was
found consistently correlated positively with a well-
established 20-item measure and consistently predicted
relapse to substance use in a sample of substance use
disorder treatment-seeking young adults in the United
States.34 In another study among female university stu-
dents in the UK, researchers found that a single-item
measure of self-efficacy was a significant predictor of
well-being as was the validated 10-item measure of gen-
eral self-efficacy.35 These findings suggest that using
single psychometric measures may offer a valid
approach to investigating overall well-being as well
as other health-seeking behavior and health-
related outcomes.
Previous research in low-resource settings has exam-
ined the correlations between self-efficacy related to
specific behaviors with HIV testing practice among
the general population and the results were mixed.
A community survey in Namibia20 reported that great-
er self-efficacy for HIV prevention behaviors (ability to
enact behaviors preventing HIV infection) was associ-
ated with lifetime HIV testing. Similarly, one study
found that HIV prevention self-efficacy was positively
associated with previous HIV testing among the gener-
al adolescent and adult population in eight urban dis-
tricts of Malawi.19 However, another community-
based study in 11 southern districts of Malawi reported
that self-efficacy to protect oneself from exposure to
risks of HIV infection was not associated with HIV
testing in the past 12 months.36 Studies among MSM
in Australia,33 Italy,13 and Hong Kong31 have shown
that self-efficacy was positively associated with self-
reported HIV testing. A study among young people
aged 18–24 years in South Africa found that HIV
risk reduction self-efficacy was not a determinant of
HIV testing,37 while another study among sexually
active young people aged 15–24 years in Thailand
reported that self-efficacy for HIV testing was associ-
ated with ever being tested for HIV.38 These findings,
although useful and indicative, cannot be generalized
to YMSM populations in low-resource settings.
In this study, we found no clear evidence on the
difference between the impact of high and moderate
self-efficacy on HIV testing uptake. However, as differ-
ent specific self-efficacy beliefs and measurements were
employed and there is a paucity of available data on the
relationship between self-efficacy and HIV testing
among key populations in low-resource settings, con-
solidation of evidence for guiding public health inter-
ventions is a challenge. Therefore, future research may
benefit from using standardized, validated self-efficacy
scales39 to measure self-efficacy as a global construct
underlying a basic belief in one’s capabilities to exercise
control over their own functioning in various challeng-
ing situations rather than self-beliefs related to specific
behaviors or learnt behaviors. There is also a need to
develop and validate a standardized self-efficacy scale
specific to HIV testing for research examining the rela-
tionship between this psychosocial factor and HIV test-
ing behavior. This may help to provide needed
information and facilitate the synthesis of evidence to
draw conclusions on effects of self-efficacy on HIV test-
ing and inform the design of public health interventions
to improve HIV testing uptake among target
populations.
Results of our study support the argument that the
inclusion of seed data in RDS analyses can provide
unbiased estimates. We show that when using RDS
estimator II, the inclusion of seed data in the final anal-
ysis can produce accurate population estimates. We
estimate that only 38% of YMSM in Myanmar have
been tested for HIV in the past three months while
more than a third (34.5%) has never been tested.
This finding raises an alarm for the national health
policy makers in Myanmar where the majority of
newly-diagnosed HIV-infected cases were found
among young key populations, particularly YMSM
aged less than 25 years who experience an HIV infec-
tion rate five times higher than that of their peers in the
general population.40 This is also an indication that the
reported HIV prevalence of 6.6% among MSM in
Myanmar41 may be underestimated and innovative
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approaches to improve HIV testing coverage among
this marginalized population are urgently needed if
the first 90 of the 90-90-90 target (90% of HIV infected
people are diagnosed) is to be achieved. Recent studies
have shown that new approaches to HIV testing such
as home-based or HIV self-testing could be effective
and efficient in reaching more first time testers and
promoting frequent testing among MSM who were
unreached by conventional testing methods.42–45 Such
approaches may well be worth considering for
Myanmar in the years to come.
Our study findings add to the evidence that self-
efficacy for HIV testing is positively associated with
HIV testing behavior of YMSM who are at higher
risk of HIV infection but have limited access to HIV
services they need.46,47 The positive association found
in this study may indicate a potential causal relation-
ship between self-efficacy and HIV testing and public
health interventions to improve self-efficacy may help
to promote HIV testing behaviors among YMSM in
Myanmar. Our findings warrant further research to
determine the effects of individual psychosocial factors,
particularly self-efficacy on HIV testing practice among
high-risk populations in LMICs. This is an important
area of research because improving HIV testing cover-
age and increasing the proportion of people at elevated
risk of HIV infection who know their HIV status is a
key strategy to reach the 90-90-90 targets in countries
with concentrated HIV epidemics among key
populations.48
The cross-sectional design of this study does not
allow us to determine the impact of self-efficacy on
HIV testing behavior. It limits our ability to generalize
the findings and draw conclusive causal relationship
between self-efficacy and HIV testing among YMSM
in Myanmar. The direction of this relationship and its
implications for public health interventions are sub-
jected to further examinations in future studies. Our
data are self-reported and therefore can suffer from
recall and social desirability bias. The measure of
self-efficacy using a single-item statement specifically
related to HIV testing behavior does not allow us to
make direct quantitative comparisons with findings
from other studies. Nevertheless, this study provides
much-needed data related to HIV testing behavior of
a young population at high risk of HIV infection in
Myanmar. It contributes to the pool of evidence on
self-efficacy and HIV testing behavior of YMSM and
offers directions for future HIV research in Myanmar
as well as other countries in similar contexts.
In conclusion, we found that more than a third of
young MSM aged 18–24 years in Myanmar have never
tested for HIV. HIV testing self-efficacy positively cor-
relates with HIV testing behavior and future research is
needed to determine the direction of this association
and inform public health interventions targeting
YMSM in Myanmar.
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